These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11886847)

  • 41. Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.
    Abdel-Motal UM; Guay HM; Wigglesworth K; Welsh RM; Galili U
    J Virol; 2007 Sep; 81(17):9131-41. PubMed ID: 17609270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys.
    Galili U; Swanson K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7401-4. PubMed ID: 1908095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.
    Galili U; Shohet SB; Kobrin E; Stults CL; Macher BA
    J Biol Chem; 1988 Nov; 263(33):17755-62. PubMed ID: 2460463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
    Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptional regulation of alpha1,3-galactosyltransferase in embryonal carcinoma cells by retinoic acid. Masking of Lewis X antigens by alpha-galactosylation.
    Cho SK; Yeh J; Cho M; Cummings RD
    J Biol Chem; 1996 Feb; 271(6):3238-46. PubMed ID: 8621726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining the minimal size of catalytically active primate alpha 1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme.
    Henion TR; Macher BA; Anaraki F; Galili U
    Glycobiology; 1994 Apr; 4(2):193-201. PubMed ID: 8054718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.
    Galili U
    Front Mol Biosci; 2021; 8():746883. PubMed ID: 34805272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First conjugation directed traverse of gene cassettes harboring α1,3GT from fast-growing Mycobacterium smegmatis mc
    Golichenari B; Yari S; Tasbiti AH; Behravan J; Vaziri F; Ghazvini K
    Enzyme Microb Technol; 2022 May; 156():110003. PubMed ID: 35149427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay.
    Ogawa H; Galili U
    Glycoconj J; 2006 Dec; 23(9):663-74. PubMed ID: 17115279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
    Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
    Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A New Humanized Mouse Model Mimics Humans in Lacking α-Gal Epitopes and Secreting Anti-Gal Antibodies.
    Saleh FM; Chandra PK; Lin D; Robinson JE; Izadpanah R; Mondal D; Bollensdorff C; Alt EU; Zhu Q; Marasco WA; Braun SE; Abdel-Motal UM
    J Immunol; 2020 Apr; 204(7):1998-2005. PubMed ID: 32144163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Masking and reduction of the Galactose-alpha1,3-Galactose (alpha-Gal) epitope, the major xenoantigen in swine, by the glycosyltransferase gene transfection.
    Miyagawa S; Tanemura M; Koyota S; Koma M; Ikeda Y; Shirakura R; Taniguchi N
    Biochem Biophys Res Commun; 1999 Nov; 264(3):611-4. PubMed ID: 10543979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenovirus-mediated expression of antisense RNA transcripts complementary to pig alpha(1,3) galactosyltransferase mRNA inhibits expression of Gal alpha(1,3) Gal epitope.
    Xing L; Xia GH; Bai XF; Fei J; Guo LH
    Acta Pharmacol Sin; 2000 Nov; 21(11):1005-10. PubMed ID: 11501054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B.
    Bowen GP; Borgland SL; Lam M; Libermann TA; Wong NC; Muruve DA
    Hum Gene Ther; 2002 Feb; 13(3):367-79. PubMed ID: 11860704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
    Stults CL; Macher BA; Bhatti R; Srivastava OP; Hindsgaul O
    Glycobiology; 1999 Jul; 9(7):661-8. PubMed ID: 10362835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Porcine alpha1,3-galactosyltransferase: tissue-specific and regulated expression of splicing isoforms.
    Vanhove B; Goret F; Soulillou JP; Pourcel C
    Biochim Biophys Acta; 1997 Mar; 1356(1):1-11. PubMed ID: 9099986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cells interacting with the alpha-Gal epitope: studies in alpha1, 3Galactosyltransferase knock-out mice.
    Tanemura M; Galili U
    Transplant Proc; 2000 Aug; 32(5):921-3. PubMed ID: 10936273
    [No Abstract]   [Full Text] [Related]  

  • 58. L-rhamnose antigen: a promising alternative to α-gal for cancer immunotherapies.
    Chen W; Gu L; Zhang W; Motari E; Cai L; Styslinger TJ; Wang PG
    ACS Chem Biol; 2011 Feb; 6(2):185-91. PubMed ID: 21043478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
    Mohiuddin MM; Ogawa H; Yin DP; Galili U
    Blood; 2003 Jul; 102(1):229-36. PubMed ID: 12649147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The possibility of reducing xenoantigen levels with a novel gal 3'-sulfotransferase (GP3ST).
    Koma M; Miyagawa S; Honke K; Nakai R; Miyoshi S; Ohta M; Matsuda H; Shirakura R; Taniguchi N
    J Biochem; 2002 Apr; 131(4):517-22. PubMed ID: 11926988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.